Yuichi Kato Selected Research

Yuichi Kato Research Topics

Disease

4	Anemia 01/2016 - 04/2014
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2023 - 01/2023
3	Infections 06/2020 - 06/2003
3	Lymphoma (Lymphomas) 01/2019 - 11/2012
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 01/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2018 - 03/2014
2	Facial Pain (Myofacial Pain) 06/2023 - 12/2014
2	Trisomy 18 Syndrome 01/2019 - 03/2015
2	Acute Lung Injury 11/2018 - 12/2017
2	Pure Red-Cell Aplasia 01/2016 - 12/2012
2	Respiratory Syncytial Virus Infections 12/2012 - 06/2011
1	Neoplasms (Cancer) 03/2024
1	Pain (Aches) 01/2023
1	Back Pain (Backache) 01/2023
1	Low Back Pain (Lumbago) 01/2023
1	Paresthesia (Dysesthesia) 01/2023
1	Starvation 09/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2022
1	Myocardial Infarction 02/2022
1	Type 2 Diabetes Mellitus (MODY) 02/2022
1	Pathologic Constriction (Stenosis) 02/2022
1	Osteoarthritis 09/2021
1	Conversion Disorder (Astasia Abasia) 11/2020
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Disease Progression 11/2018
1	Hematologic Neoplasms (Hematological Malignancy) 11/2018
1	protothecosis 04/2018
1	Mastitis 04/2018
1	Rheumatoid Arthritis 01/2018
1	Bronchopulmonary Dysplasia 12/2017
1	Chorioamnionitis 12/2017
1	Alzheimer Disease (Alzheimer's Disease) 07/2017
1	Wounds and Injuries (Trauma) 03/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016
1	Fever (Fevers) 06/2015
1	Apnea 03/2015
1	Headache (Headaches) 12/2014
1	Hyperbilirubinemia 03/2014

Drug/Important Bio-Agent (IBA)

2	Dopamine (Intropin)FDA LinkGeneric 06/2023 - 01/2023
2	Aripiprazole (Abilify)FDA Link 06/2023 - 01/2023
2	NitrogenIBA 09/2022 - 01/2016
2	ranimustineIBA 11/2018 - 11/2012
2	Dasatinib (BMS 354825)FDA Link 07/2018 - 02/2016
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 01/2016
2	Immunoglobulin M (IgM)IBA 12/2017 - 06/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 12/2012
2	AdiponectinIBA 01/2016 - 04/2014
2	Rituximab (Mabthera)FDA Link 01/2016 - 09/2012
1	LUFIBA 03/2024
1	Methylphenidate (Ritalin)FDA LinkGeneric 06/2023
1	AN 3IBA 01/2023
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2023
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2023
1	Therapeutic UsesIBA 01/2023
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2023
1	LipidsIBA 09/2022
1	CopperIBA 11/2020
1	ElectrolytesIBA 11/2020
1	AmidesIBA 11/2020
1	Phosphates (Orthophosphate)IBA 11/2020
1	ceric oxide (cerium dioxide)IBA 11/2020
1	LithiumIBA 11/2020
1	SolutionsIBA 06/2020
1	AntibodiesIBA 01/2019
1	GangliosidesIBA 01/2019
1	NucleotidesIBA 04/2018
1	Ribosomal DNA (rDNA)IBA 04/2018
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	sirukumabIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	sivelestatIBA 12/2017
1	SodiumIBA 12/2017
1	Secretory Proteinase Inhibitory ProteinsIBA 12/2017
1	Amyloid (Amyloid Fibrils)IBA 07/2017
1	CarbonIBA 03/2017
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	Amylases FDA Link 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	Natriuretic PeptidesIBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	AlbuminsIBA 06/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2015
1	CreatinineIBA 04/2014
1	nilotinib FDA Link 03/2014
1	Imatinib Mesylate (Gleevec)FDA Link 03/2014

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2023 - 01/2002
4	Therapeutics 11/2018 - 01/2002
3	Stem Cell Transplantation 01/2019 - 11/2012
2	Aftercare (After-Treatment) 01/2023 - 12/2014
2	Salvage Therapy 11/2018 - 11/2012
1	Percutaneous Coronary Intervention 02/2022
1	Stents 02/2022
1	Osteotomy 09/2021
1	Electrodes (Electrode) 11/2020
1	Critical Care (Surgical Intensive Care) 01/2019
1	Cell Transplantation 01/2019
1	Lasers (Laser) 04/2018
1	Hematopoietic Stem Cell Transplantation 01/2016
1	Artificial Respiration (Mechanical Ventilation) 03/2015